FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Veterinary parasitology2014; 204(3-4); 291-296; doi: 10.1016/j.vetpar.2014.04.013

Decreased strongyle egg re-appearance period after treatment with ivermectin and moxidectin in horses in Belgium, Italy and The Netherlands.

Abstract: The objective of the present study was to evaluate the efficacy of an oral treatment with ivermectin (IVM) or moxidectin (MOX) against gastro-intestinal strongyles in naturally infected horses by performing a faecal egg count reduction test (FECRT) and by monitoring the egg reappearance period (ERP) after treatment. Therefore, a field efficacy study with a randomised complete block design for each study site was conducted, with the individual animal as the experimental unit. At least 10 study sites in Italy, Belgium and The Netherlands were selected and animals were allocated to one of the two treatment groups based on the pre-treatment faecal egg counts (FEC). Animals were treated on Day 0 with an oral paste containing either IVM (at 0.2mg/kg bodyweight) or MOX (at 0.4 mg/kg bodyweight). After treatment, faecal samples were collected at least every fortnight during 56 days after treatment with IVM and during 84 days after MOX treatment. In total, 320 horses on 32 farms were examined. The FECRT on Day 14 indicated a 100% efficacy in 59 of the 64 treatment groups and >92% efficacy in the remaining 5 groups. The ERP was decreased for at least one of the anthelmintics on 17 out of 32 study sites (15 sites or 47% for MOX and 17 sites or 53% for IVM) and on 9 sites (28%) the ERP was decreased for both anthelmintics. On some of these study sites the efficacy declined at the end of the expected ERP, often with good efficacy 2 weeks earlier. Nevertheless, on 1, 3 and 5 study sites in Italy, Belgium and The Netherlands respectively, an efficacy below 90% for IVM and MOX was identified as soon as Day 42 or Day 56. In The Netherlands, the efficacy of IVM was below 90% from Day 28 or Day 35 after treatment on 1 site each. The present study reports a high efficacy of MOX and IVM in a FECRT 14 days after treatment, yet does indicate a shortened ERP for these treatments in more than half of the selected study sites.
Copyright © 2014 Elsevier B.V. All rights reserved.
Get Full Text
Publication Date: 2014-04-26 PubMed ID: 24880643DOI: 10.1016/j.vetpar.2014.04.013Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research is focused on studying the effectiveness of two drugs, ivermectin and moxidectin, on treating digestive system parasites in horses. The study shows a high efficacy in reducing the faecal egg count for both drugs. However, the study also reveals a reduction in the egg reappearance period after treatment in more than half of the study sites.

Explanation of the Study

This study aimed to evaluate the efficacy of ivermectin (IVM) and moxidectin (MOX), two anthelmintics, in treating gastro-intestinal strongyles (a type of roundworm) in horses. This was measured by:

  • Performing a faecal egg count reduction test (FECRT) to assess the decrease in parasite eggs after treatment
  • Monitoring the egg reappearance period (ERP), defining how long it takes for the eggs to reappear in the faecal matter after treatment

This was a field efficacy study, conducted in Belgium, Italy, and The Netherlands with a randomized complete block design at each study site.

The Horses were divided into two groups based on their initial faecal egg counts (FEC). They were then treated with either IVM or MOX. Post-treatment, faecal samples were collected from the horses regularly for different durations based on the treatment they received—56 days for IVM and 84 days for MOX.

Findings of the Study

The research encompassed 320 horses across 32 farms. Two weeks after administering the drugs, the FECRT showed a 100% reduction in 59 out of the 64 treatment groups, and more than 92% efficacy in the remaining five.

However, the research also found that the ERP was shortened in at least one of the treatments in 17 of the 32 study sites. On 9 of those sites, both drugs resulted in a decreased ERP. In certain locations where a decrease in ERP was recorded, there was also a drop in efficacy at the end of the expected ERP.

The study also found cases where the efficacy of the drugs was below 90% as soon as the 42nd or 56th day after treatment.

Summary of Findings

Though the study demonstrated a high efficacy of MOX and IVM in a faecal egg count reduction test 14 days after treatment, it also pointed out a shortened egg reappearance period at more than half of the selected study sites. This implies that while these treatments may be highly effective in terms of initial parasite clearance, their long-term effectiveness might be compromised. The study’s revelations about these drugs’ shortened ERP could have implications for how they are used in veterinary practice for parasite control in horses.

Cite This Article

APA
Geurden T, van Doorn D, Claerebout E, Kooyman F, De Keersmaecker S, Vercruysse J, Besognet B, Vanimisetti B, di Regalbono AF, Beraldo P, Di Cesare A, Traversa D. (2014). Decreased strongyle egg re-appearance period after treatment with ivermectin and moxidectin in horses in Belgium, Italy and The Netherlands. Vet Parasitol, 204(3-4), 291-296. https://doi.org/10.1016/j.vetpar.2014.04.013

Publication

Veterinary parasitology
ISSN: 1873-2550
NlmUniqueID: 7602745
Country: Netherlands
Language: English
Volume: 204
Issue: 3-4
Pages: 291-296
PII: S0304-4017(14)00222-2

Researcher Affiliations

Geurden, Thomas
  • Zoetis, Mercuriuslaan 20, 1930 Zaventem, Belgium. Electronic address: thomasgeurden@yahoo.com.
van Doorn, Deborah
  • Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584 CL Utrecht, The Netherlands.
Claerebout, Edwin
  • Laboratory for Parasitology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.
Kooyman, Frans
  • Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584 CL Utrecht, The Netherlands.
De Keersmaecker, Sofie
  • Zoetis, Mercuriuslaan 20, 1930 Zaventem, Belgium.
Vercruysse, Jozef
  • Laboratory for Parasitology, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium.
Besognet, Bruno
  • Zoetis, Mercuriuslaan 20, 1930 Zaventem, Belgium.
Vanimisetti, Bindu
  • Zoetis, Mercuriuslaan 20, 1930 Zaventem, Belgium.
di Regalbono, Antonio Frangipane
  • Department of Animal Medicine, Production and Health, University of Padova, Viale dell'Università 16, 35020 Legnaro, PD, Italy.
Beraldo, Paola
  • Faculty of Veterinary Medicine, University of Udine, Via delle Scienze 206, 33100 Udine, Italy.
Di Cesare, Angela
  • Faculty of Veterinary Medicine, University of Teramo, Piazza A. Moro 45, 64100 Teramo, Italy.
Traversa, Donato
  • Faculty of Veterinary Medicine, University of Teramo, Piazza A. Moro 45, 64100 Teramo, Italy.

MeSH Terms

  • Animals
  • Anthelmintics / therapeutic use
  • Belgium / epidemiology
  • Feces / parasitology
  • Female
  • Horse Diseases / drug therapy
  • Horse Diseases / epidemiology
  • Horses
  • Italy / epidemiology
  • Ivermectin / therapeutic use
  • Macrolides / therapeutic use
  • Netherlands / epidemiology
  • Parasite Egg Count / veterinary
  • Strongyle Infections, Equine / drug therapy
  • Strongyle Infections, Equine / epidemiology

Citations

This article has been cited 19 times.
  1. Bull KE, Allen KJ, Hodgkinson JE, Peachey LE. The first report of macrocyclic lactone resistant cyathostomins in the UK. Int J Parasitol Drugs Drug Resist 2023 Apr;21:125-130.
    doi: 10.1016/j.ijpddr.2023.03.001pubmed: 36940551google scholar: lookup
  2. Macdonald SL, Abbas G, Ghafar A, Gauci CG, Bauquier J, El-Hage C, Tennent-Brown B, Wilkes EJA, Beasley A, Jacobson C, Cudmore L, Carrigan P, Hurley J, Beveridge I, Hughes KJ, Nielsen MK, Jabbar A. Egg reappearance periods of anthelmintics against equine cyathostomins: The state of play revisited. Int J Parasitol Drugs Drug Resist 2023 Apr;21:28-39.
    doi: 10.1016/j.ijpddr.2022.12.002pubmed: 36543048google scholar: lookup
  3. Baranova MV, Panova OA, Polukhina DN, Panova DS. Reduction of the nematode egg reappearance period in horses after anthelmintic therapy. Vet World 2022 Jun;15(6):1530-1534.
    doi: 10.14202/vetworld.2022.1530-1534pubmed: 35993067google scholar: lookup
  4. Abbas G, Ghafar A, Hurley J, Bauquier J, Beasley A, Wilkes EJA, Jacobson C, El-Hage C, Cudmore L, Carrigan P, Tennent-Brown B, Gauci CG, Nielsen MK, Hughes KJ, Beveridge I, Jabbar A. Cyathostomin resistance to moxidectin and combinations of anthelmintics in Australian horses. Parasit Vectors 2021 Dec 4;14(1):597.
    doi: 10.1186/s13071-021-05103-8pubmed: 34863271google scholar: lookup
  5. Zanet S, Battisti E, Labate F, Oberto F, Ferroglio E. Reduced Efficacy of Fenbendazole and Pyrantel Pamoate Treatments against Intestinal Nematodes of Stud and Performance Horses. Vet Sci 2021 Mar 5;8(3).
    doi: 10.3390/vetsci8030042pubmed: 33807857google scholar: lookup
  6. Dauparaitė E, Kupčinskas T, von Samson-Himmelstjerna G, Petkevičius S. Anthelmintic resistance of horse strongyle nematodes to ivermectin and pyrantel in Lithuania. Acta Vet Scand 2021 Jan 25;63(1):5.
    doi: 10.1186/s13028-021-00569-zpubmed: 33494770google scholar: lookup
  7. Roelfstra L, Quartier M, Pfister K. Preliminary Data from Six Years of Selective Anthelmintic Treatment on Five Horse Farms in France and Switzerland. Animals (Basel) 2020 Dec 15;10(12).
    doi: 10.3390/ani10122395pubmed: 33333748google scholar: lookup
  8. Nielsen MK, Banahan M, Kaplan RM. Importation of macrocyclic lactone resistant cyathostomins on a US thoroughbred farm. Int J Parasitol Drugs Drug Resist 2020 Dec;14:99-104.
    doi: 10.1016/j.ijpddr.2020.09.004pubmed: 33022574google scholar: lookup
  9. Leathwick DM, Sauermann CW, Nielsen MK. Managing anthelmintic resistance in cyathostomin parasites: Investigating the benefits of refugia-based strategies. Int J Parasitol Drugs Drug Resist 2019 Aug;10:118-124.
    doi: 10.1016/j.ijpddr.2019.08.008pubmed: 31491731google scholar: lookup
  10. Sanna G, Pipia AP, Tamponi C, Manca R, Varcasia A, Traversa D, Scala A. Anthelmintics efficacy against intestinal strongyles in horses of Sardinia, Italy. Parasite Epidemiol Control 2016 Jun;1(2):15-19.
    doi: 10.1016/j.parepi.2016.01.001pubmed: 29988184google scholar: lookup
  11. Sallé G, Kornaś S, Basiaga M. Equine strongyle communities are constrained by horse sex and species dipersal-fecundity trade-off. Parasit Vectors 2018 May 2;11(1):279.
    doi: 10.1186/s13071-018-2858-9pubmed: 29716644google scholar: lookup
  12. Clark A, Sallé G, Ballan V, Reigner F, Meynadier A, Cortet J, Koch C, Riou M, Blanchard A, Mach N. Strongyle Infection and Gut Microbiota: Profiling of Resistant and Susceptible Horses Over a Grazing Season. Front Physiol 2018;9:272.
    doi: 10.3389/fphys.2018.00272pubmed: 29618989google scholar: lookup
  13. Hernández JA, Vázquez-Ruiz RA, Cazapal-Monteiro CF, Valderrábano E, Arroyo FL, Francisco I, Miguélez S, Sánchez-Andrade R, Paz-Silva A, Arias MS. Isolation of Ovicidal Fungi from Fecal Samples of Captive Animals Maintained in a Zoological Park. J Fungi (Basel) 2017 Jun 2;3(2).
    doi: 10.3390/jof3020029pubmed: 29371547google scholar: lookup
  14. Molena RA, Peachey LE, Di Cesare A, Traversa D, Cantacessi C. Cyathostomine egg reappearance period following ivermectin treatment in a cohort of UK Thoroughbreds. Parasit Vectors 2018 Jan 25;11(1):61.
    doi: 10.1186/s13071-018-2638-6pubmed: 29370872google scholar: lookup
  15. Sallé G, Cortet J, Bois I, Dubès C, Guyot-Sionest Q, Larrieu C, Landrin V, Majorel G, Wittreck S, Woringer E, Couroucé A, Guillot J, Jacquiet P, Guégnard F, Blanchard A, Leblond A. Risk factor analysis of equine strongyle resistance to anthelmintics. Int J Parasitol Drugs Drug Resist 2017 Dec;7(3):407-415.
    doi: 10.1016/j.ijpddr.2017.10.007pubmed: 29149701google scholar: lookup
  16. Zak A, Siwinska N, Slowikowska M, Borowicz H, Kubiak K, Hildebrand J, Popiolek M, Niedzwiedz A. Searching for ivermectin resistance in a Strongylidae population of horses stabled in Poland. BMC Vet Res 2017 Jul 3;13(1):210.
    doi: 10.1186/s12917-017-1133-1pubmed: 28673347google scholar: lookup
  17. Schneider S, Pfister K, Becher AM, Scheuerle MC. Strongyle infections and parasitic control strategies in German horses - a risk assessment. BMC Vet Res 2014 Nov 12;10:262.
    doi: 10.1186/s12917-014-0262-zpubmed: 25387542google scholar: lookup
  18. Elghryani N, Lawlor A, McOwan T, de Waal T. Unravelling the Effectiveness of Anthelmintic Treatments on Equine Strongyles on Irish Farms. Animals (Basel) 2024 Jul 2;14(13).
    doi: 10.3390/ani14131958pubmed: 38998069google scholar: lookup
  19. Nielsen MK. Anthelmintic resistance in equine nematodes: Current status and emerging trends. Int J Parasitol Drugs Drug Resist 2022 Dec;20:76-88.
    doi: 10.1016/j.ijpddr.2022.10.005pubmed: 36342004google scholar: lookup
Subscribe to our newsletter
Join 99,658 horse owners like you who receive our email updates on horse health and nutrition.